[Alpha-lipoic acid in the treatment of diabetic polyneuropathy].  The issues of classification, pathogenesis, pathomorphology and treatment of diabetic polyneuropathy (DPN) are addressed.
Pathogenetic mechanisms of the action of alpha-lipoic acid in treatment of DPN are justified.
The authors present the results of randomized placebo-controlled trials of alpha-lipoic acid that revealed the high clinical efficacy and absence of side-effects even during the long-term treatment.
